View Older Stories View More Recent Stories

Aug 5, 2021 08:00AM Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
Aug 3, 2021 08:12AM Lumos Pharma, Inc. (LUMO) Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
Aug 3, 2021 08:00AM Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
Aug 3, 2021 08:00AM Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
Aug 2, 2021 08:04AM Lumos Pharma, Inc. (LUMO) Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
Aug 2, 2021 08:00AM Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
Aug 2, 2021 08:00AM Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
Jul 26, 2021 04:18PM Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
Jul 26, 2021 04:18PM Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
Jul 22, 2021 08:00AM Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
Jul 22, 2021 08:00AM Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
Jul 20, 2021 04:04PM Lumos Pharma (LUMO) issues new guidance concerning the Phase 2 OraGrowtH210 Trial of LUM-201 in PGHD
Jul 20, 2021 04:01PM Lumos Pharma Announces Clinical Updates
Jul 20, 2021 04:01PM Lumos Pharma Announces Clinical Updates
Jun 28, 2021 08:00AM Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
Jun 28, 2021 08:00AM Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
May 19, 2021 09:00AM Lumos Pharma to Participate in the Jefferies Virtual Healthcare Conference
May 19, 2021 09:00AM Lumos Pharma to Participate in the Jefferies Virtual Healthcare Conference
May 13, 2021 09:00AM Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
May 13, 2021 09:00AM Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
May 5, 2021 04:01PM Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
May 5, 2021 04:01PM Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
Apr 28, 2021 09:00AM Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021
Apr 28, 2021 09:00AM Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021
Apr 27, 2021 08:00AM Newly Released Data on Three PGHD Patients Treated with LUM-201 in Prior Phase 2 Study To Be Presented in Lumos Pharma Key Opinion Leader Webinar
Apr 27, 2021 08:00AM Newly Released Data on Three PGHD Patients Treated with LUM-201 in Prior Phase 2 Study To Be Presented in Lumos Pharma Key Opinion Leader Webinar
Apr 20, 2021 04:14PM Lumos Pharma (LUMO) Announces Retirement of Carl Langren and Names Lori Lawley CFO in Planned Succession
Apr 20, 2021 04:05PM Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
Apr 20, 2021 04:05PM Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
Apr 14, 2021 04:05PM Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Apr 14, 2021 04:05PM Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Mar 20, 2021 11:00AM Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Mar 20, 2021 11:00AM Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Mar 11, 2021 04:05PM Lumos Pharma to Participate in March 2021 Investor Conferences
Mar 11, 2021 04:05PM Lumos Pharma to Participate in March 2021 Investor Conferences
Mar 9, 2021 04:05PM Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Mar 9, 2021 04:05PM Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Mar 4, 2021 09:05AM Lumos Pharma (LUMO) Says Data Supporting Use of Predictive Enrichment Markers for its LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Dec 18, 2020 09:00AM Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
Dec 18, 2020 09:00AM Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
Nov 23, 2020 07:43PM Lumos Pharma to Participate in December Investor Conferences
Nov 23, 2020 07:42PM Lumos Pharma to Participate in December Investor Conferences
View More Recent Stories View Older Stories